Primary prophylaxis of venous thromboembolism in children.
Venous thromboembolism (VTE) is rare in children and young adolescents, and occurs predominantly in those with congenital heart disease in whom guidelines exist for VTE prophylaxis. For other paediatric patients, the rarity of the event makes writing an evidence-based clinical practice guideline difficult because each of the known risk factors contributes only a small increase in risk. Thrombophilia screening is controversial because few results assist with prediction of likely thrombosis and may not alter recommendations for prophylaxis. Recent publications highlight the importance of non-pharmacological prevention of VTE in children and adolescents undergoing surgery and the importance of liaison among surgeon, anaesthetist and haematologist. This annotation was written with the aim of collating current evidence for VTE prophylaxis and emphasising the need for further research in vulnerable subgroups.
Cole
Catherine H
CH
School of Paediatrics and Child Health, University of Western Australia, Department of Haematology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia. catherine.cole@health.wa.gov.au
D000293:Adolescent; D002648:Child; D042241:Early Diagnosis; D019317:Evidence-Based Medicine; D006801:Humans; D008403:Mass Screening; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*